Compare Cardinal Health Inc (CAH) vs Yum! Brands, Inc. (YUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Yum! Brands, Inc. — how do they compare? Cardinal Health Inc trades at $225.38 (market cap $52.42B), while Yum! Brands, Inc. trades at $137.99 (market cap $37.05B). The key difference: Cardinal Health Inc is the larger of the two by market cap, and Yum! Brands, Inc. pays the higher dividend (2.21%). Which is the better fit depends on your goals — on Pluang, investors hold Cardinal Health Inc for 69 Days and Yum! Brands, Inc. for 131 Days on average.
| CAH | YUM | |
|---|---|---|
Market Cap | $52.42B | $37.05B |
Volume | 4,140,836 | 2,016,599 |
Sector | Health | Consumer Cyclical |
52-Week High | $248.61 | $168.16 |
52-Week Low | $147.47 | $135.77 |
Typical Hold Time | 69 Days | 131 Days |
Enterprise Value | $56.45B | $48.65B |
Dividend Yield | 0.92% | 2.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $225.38, down 3.08% on the day, with a mixed technical picture showing bullish oscillators but bearish moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.91 exceeding the $2.42 estimate. Revenue for 2025 reached $222.58B, though net margins remain thin at 0.67%. Recent news highlights IRA pricing changes as a potential headwind, while institutional buying and conference participation indicate ongoing interest.
The outlook is cautiously optimistic, supported by analyst consensus favoring Buy ratings and a $273.22 price target implying 21% upside. Key opportunities include specialty growth and tech-enabled platform expansion, but risks involve margin pressure from regulatory changes and high debt levels. The stock's valuation at a P/E of 31.31 may limit near-term gains if earnings growth slows.
YUM! Brands trades at $137.99, down 0.07% with bearish technical signals despite recent earnings beats. The company shows strong fundamentals with $8.21B revenue (2025), 25.4% net margin, and positive cash flow trends. Recent Pizza Hut sale for $1.5B will reduce debt and fund buybacks, while quarterly dividend of $0.75 provides shareholder returns. Analyst consensus is mixed with 41% buy ratings but technical indicators show selling pressure near key resistance at $138.
YUM presents a value opportunity with reasonable P/E of 17.1 and 28% upside to consensus target of $172.38, though high debt levels and consumer spending sensitivity pose risks. The leaner portfolio focusing on KFC and Taco Bell post-Pizza Hut sale could drive efficiency, but investor sentiment remains cautious amid sector headwinds and ongoing legal investigations noted in recent filings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Yum! Brands, Inc.
Yum Brands is a U.S.-based restaurant operator featuring a portfolio of four brands: KFC (26,930 global units), Pizza Hut (18,380 units), Taco Bell (7,790 units), and The Habit Burger (310 units) at year-end 2021. With $58 billion in 2021 systemwide sales, the firm is the second-largest restaurant company in the world, behind McDonald's ($112.5 billion) but ahead of Restaurant Brands International ($36 billion) and Starbucks ($25 billion). Yum is 98% franchised, with the largest franchisee, Yum China, created via a 2016 spinoff transaction (after which Yum China agreed to pay 3% royalties to Yum Brands in perpetuity). Yum is the newest evolution of Tricon Brands, formerly a division of PepsiCo, and generates the bulk of its revenue from franchise royalties and marketing contributions.
Read more on YUM →
